The switch from transcriptionally activating MYC-MAX to transcriptionally repressing MAD1-MAX protein heterodimers has been correlated with the initiation of terminal differentiation in many cell types. To investigate the function of MAD1-MAX dimers during differentiation, we disrupted the Mad1 gene by homologous recombination in mice. Analysis of hematopoietic differentiation in homozygous mutant animals revealed that cell cycle exit of granulocytic precursors was inhibited following the colony-forming cell stage, resulting in increased proliferation and delayed terminal differentiation of low proliferative potential cluster-forming cells. Surprisingly, the numbers of terminally differentiated bone marrow and peripheral blood granulocytes were essentially unchanged in Mad1 null mice. This imbalance between the frequencies of precursor and mature granulocytes was correlated with a compensatory decrease in granulocytic clusterforming cell survival under apoptosis-inducing conditions. In addition, recovery of the peripheral granulocyte compartment following bone marrow ablation was significantly enhanced in Mad1 knockout mice. Two Mad1-related genes, Mxi1 and Mad3, were found to be expressed ectopically in adult spleen, indicating that functional redundancy and cross-regulation between MAD family members may allow for apparently normal differentiation in the absence of MAD1. These findings demonstrate that MAD1 regulates cell cycle withdrawal during a late stage of granulocyte differentiation, and suggest that the relative levels of MYC versus MAD1 mediate a balance between cell proliferation and terminal differentiation.
Introduction
Appropriate regulation of the opposing processes of cell proliferation and terminal differentiation is a critical aspect of normal development and homeostasis (Raff, 1996) , and is frequently disrupted during tumorigenesis (Sawyers et al., 1991) . Considerable progress has been made in
774
© Oxford University Press recent years towards understanding the signaling pathways through which environmental stimuli, such as growth factors or cell-cell interactions, regulate the commitment of multipotential precursors to specific cell lineages and their subsequent proliferation (Morrison et al., 1997) . However, the mechanisms by which these lineagecommitted cells cease to divide at the appropriate time and take on a terminally differentiated phenotype remain poorly understood.
The c-, L-and N-MYC oncoproteins (collectively termed MYC) are thought to be key regulators of proliferation in most cell types (Marcu et al., 1992; Henriksson and Lüscher, 1996) . MYC activates transcription by binding to CACGTG-response elements as a heterodimer with MAX (Blackwood and Eisenman, 1991; Prendergast et al., 1991; Amati et al., 1992; Kretzner et al., 1992) , and several candidate MYC-MAX target genes have been identified (Grandori and Eisenman, 1997) . Since MAX is widely and constitutively expressed, the formation of MYC-MAX dimers is dependent upon the rate of MYC synthesis . MYC expression is induced rapidly in response to mitogenic stimulation and is downregulated as cells exit the cell cycle and become quiescent (Kelly et al., 1982) . Several lines of evidence suggest that MYC is required as a rate-limiting step during cell cycle entry and the G 1 -S transition. For example, ectopic expression of MYC is sufficient to induce cell cycle reentry of a serum-starved fibroblast cell line (Eilers et al., 1991) , although, in the absence of survival cytokines, MYC-induced proliferation also results in apoptotic cell death (Askew et al., 1991; Evan et al., 1992) . In contrast, antisense oligonucleotides that block MYC expression inhibit cell cycle entry at the G 1 -S transition (Heikkila et al., 1987) , and targeted inactivation of MYC in mice results in mid-gestational lethality due to the failure of cell proliferation during organogenesis . Notably, MYC is down-regulated during differentiation (Westin et al., 1982; Lachman and Skoultchi, 1984) , and its ectopic expression can inhibit cell cycle withdrawal and terminal differentiation of many cell types (Coppola and Cole, 1986; Langdon et al., 1986; Freytag, 1988) .
Members of the MAD protein family (MAD1, MXI1, MAD3 and MAD4) compete with MYC for heterodimerization to MAX Zervos et al., 1993; Hurlin et al., 1995b) . However, in contrast to MYC-MAX, MAD1-MAX dimers repress transcription of CACGTG-containing genes Hurlin et al., 1995b) . Ectopic expression of MAD1 has been found to inhibit proliferation by promoting G 1 cell cycle arrest Roussel et al., 1996) , and can block transformation of rat embryo fibroblasts by Myc (Lahoz et al., 1994; Cerni et al., 1995; Koskinen et al., 1995; Västrik et al., 1995) . Ectopically expressed MAD1 can also over-ride the ability of MYC to inhibit terminal differentiation of murine erythroleukemia cells (Cultraro et al., 1997) . These activities of MADs depend upon formation of a ternary complex between MAD-MAX and mSIN3A or mSIN3B Hurlin et al., 1995b; Schreiber-Agus et al., 1995) , co-repressors that can in turn recruit histone deacetylases to target genes (Alland et al., 1997; Hassig et al., 1997; Heinzel et al., 1997; Laherty et al., 1997; Sommer et al., 1997) . Recently, a novel ubiquitously expressed MAX partner, MNT, has been identified that shares many of the attributes of MAD1 (Hurlin et al., 1997; Meroni et al., 1997) .
Further insight into the possible in vivo functions of MAD1 and its relatives has come from studies of their expression patterns. Typically, the Mad1 gene is expressed at low levels in proliferating cells and is up-regulated during terminal differentiation of most cell types Delgado et al., 1995; Gandarillas and Watt, 1995; Hurlin et al., 1995a,b; Västrik et al., 1995; Lymboussaki et al., 1996; Rao et al., 1996; Cultraro et al., 1997; Quéva et al., 1998) , often as an immediate early response to differentiation-inducing stimuli Larsson et al., 1994) . With the parallel down-regulation of MYC, this results in a switch from MYC-MAX to MAD1-MAX complexes as terminal differentiation proceeds Hurlin et al., 1995a; Cultraro et al., 1997) . The different members of the Mad gene family are expressed in distinct, yet partially overlapping patterns (Hurlin et al., 1995b; Quéva et al., 1998) . In developing mouse embryos, expression of the Mad family is first apparent with the onset of widespread differentiation during organogenesis while, in the adult, their expression is limited to tissues in which terminal differentiation is ongoing due to the presence of residual progenitor cells.
The ability of ectopic MAD1 to promote cell cycle arrest, along with the observed correlation between its expression and the commencement of terminal differentiation, has led us to propose that MAD1 negatively regulates proliferation-associated MYC target genes, thereby mediating cell cycle withdrawal and terminal differentiation. To date, however, a functional role for the MAD family during differentiation has yet to be demonstrated directly. To test this hypothesis, we have analyzed terminal differentiation in mice bearing homozygous Mad1 null mutations.
Results

Targeted disruption of the murine Mad1 gene
To examine the in vivo function of MAD1, we generated targeted disruptions of the murine Mad1 gene by homologous recombination in embryonic stem (ES) cells. Two different gene replacement vectors were designed, pMad1 tm1 ( Figure 1A ) and pMad1 tm2 (not shown), in which overlapping portions of the Mad1 first exon and promoter region were deleted and replaced by the neomycin resistance (neo) gene. Following standard procedures, ES cells were electroporated with the targeting vectors, placed under positive/negative selection, and the surviving colonies screened for homologous recombination by PCR and Southern blotting ( Figure 1A ). Correct gene targeting occurred in ™18-32% of surviving Mad1 tm1 and 94% of Mad1 tm2 clones. Homologous recombination by both of 775 these vectors was expected to result in the generation of null alleles due to deletion of the translation initiation codon, as well as the mSIN3 co-repressor interaction domain that is required for MAD1 function .
Three lines of knockout mice, representing one Mad1 tm1 and two Mad1 tm2 ES cell clones, were derived on the inbred 129/Sv genetic background. The progeny of matings between heterozygotes were analyzed by Southern blotting to identify wild-type (Mad1 ϩ/ϩ ), heterozygous and homozygous (Mad1 -/-) mutant offspring ( Figure 1B ), which were found to be present at the expected Mendalian ratio (24:50:26, respectively; n ϭ 262). Mad1 -/-animals were viable, appeared outwardly normal and showed no obvious differences in size, behavior, reproductive ability, incidence of neoplasia or life spans when compared with Mad1 ϩ/ϩ littermates. For the experiments described below, similar phenotypes were observed for each line, as well as for animals on the hybrid 129B6F2 and N 4 -C57BL/6 genetic backgrounds.
To confirm that the Mad1 gene was disrupted successfully, Mad1 expression was examined by RT-PCR using primers specific for downstream exons which were not deleted by the gene targeting events. No Mad1 expression was detected in any adult tissues from Mad1 -/-mice ( Figure 1C ), demonstrating that null alleles had indeed been generated. The lack of Mad1 expression was also confirmed by mRNA in situ hybridization analysis of embryonic and adult tissues, as described below (see Figure 7A and B).
Analysis of myeloid differentiation in Mad1 knockout mice
The hematopoietic system is particularly amenable for studying the switch from proliferation to terminal differentiation. Since MAD1 is induced as proliferating cells commit to terminal differentiation, we therefore proceeded carefully to examine hematopoiesis in these animals. Adult Mad1 -/-and Mad1 ϩ/ϩ littermates (8-11 weeks old) were analyzed by fluorescence-activated cell sorting (FACS) using antibodies to lineage-specific cell surface markers. We found a modest but statistically significant increase in the frequency of mature granulocytes in the bone marrow of Mad1 -/-mice ( Figure 2A and B, see Gran/Mac and Gran). Since homeostatic compensation can often ameliorate more severe underlying defects, we proceeded to investigate this observation further. In vitro bone marrow colony assays were performed in semi-solid media in the presence of concentrations of recombinant cytokines that were empirically determined to promote maximal cell proliferation and survival. The ability of bone marrow precursors to proliferate in vitro can be used to classify their stages of differentiation (Metcalf, 1984) . Typically, immature lineage-committed colony-forming cells (CFCs) form groups of~50 or more mostly terminally differentiated cells after 7 days of culture, whereas more mature cluster-forming cells (cluster-FCs) with very limited proliferative potential form smaller groups of 4-16 terminally differentiated cells after 2 days of culture, which then fail to proliferate further. To examine the frequencies of these two different stages of myeloid cell differentiation, bone marrow cultures were stimulated with granulocyte-macrophage colony-stimulating factor (GM-CSF) to promote , structure of the pMad1 tm1 targeting vector (Vector) and resulting homologous recombinant allele (Mad1 tm1 ) in which the Mad1 promoter and first exon (containing the 5Ј untranslated region and translational initiation codon) were deleted. E1 and E2 represent exons 1 and 2, respectively. neo and thymidine kinase (tk) genes under control of the mouse phosphoglycerate kinase 1 (PGK) promoter were used as positive and negative selectable markers, respectively. Crosses indicate expected areas of homologous recombination. PCR primers K15 and K16 (black arrowheads) were used to screen ES cell clones initially for correct homologous recombination. PCR-positive clones were analyzed with Southern probes A and B (horizontal bars) to confirm the recombinant 5Ј and 3Ј junctions, respectively. Also indicated are the expected sizes of XbaI bands (horizontal dashed lines) representing the wild-type and Mad1 tm1 alleles detected by Southern hybridization with 3Ј probe B. (B) Genomic Southern blot analysis using 3Ј probe B of XbaI-digested tail DNA from progeny of a Mad1 ϩ/-ϫMad1 ϩ/-mating. (C) Denaturing polyacrylamide gel electrophoresis of radiolabeled RT-PCR reactions to detect Mad1 expression in tissues from a Mad1 tm1 homozygous mutant and wild-type littermate confirms that a null mutation was generated. Independent RT-PCR amplification of ribosomal protein S16 mRNA was used as a control for efficient cDNA synthesis. The doublet bands observed for both Mad1 and S16 are probably due to independent migration of amplification product strands under denaturing conditions. Similar results were obtained for homozygous Mad1 tm2 mice. Wild-type (ϩ/ϩ); heterozygote (ϩ/-); homozygous mutant (-/-). the survival and proliferation of both granulocytes and macrophages. We observed a 3-fold increase in the frequency of cluster-FCs in Mad1 -/-cultures when compared with control cultures from Mad1 ϩ/ϩ littermates ( Figure  2A ). Analysis of fixed cultures indicated that this increase represented predominantly granulocytic rather than macrophage clusters. Consistent with this, an increased frequency of granulocytic cluster-FCs was also observed when Mad1 -/-bone marrow was stimulated with granulocyte colony-stimulating factor (G-CSF) ( Figure 2B ), which promotes the survival and proliferation of granulocytes but not macrophages. The frequency of granulocytic cluster-FCs in Mad1 ϩ/-heterozygotes was found to be intermediate between those of Mad1 ϩ/ϩ and Mad1 -/-mice (data not shown).
Importantly, no significant differences were found in the frequency of more immature granulocytic CFCs stimulated with either GM-or G-CSF (Figure 2A and B), suggesting a requirement for MAD1 only during the latter stages of granulocyte differentiation. This observation is consistent with the expression pattern of MAD1 protein in the murine granulocytic precursor cell line, MPRO, which can be induced to terminally differentiate by a retinoic acid receptor (RXR) agonist (Tsai and Collins, 1993; S.Collins, personal communication) . Following treatment with the agonist, MAD1 expression was up-regulated in proliferating MPRO cells concomitant with the onset of cell cycle withdrawal, and reached a maximum in post-mitotic cells that exhibited a mature granulocyte morphology and expressed high levels of the Gr-1 differentiation marker In vitro hematopoietic colony formation from Mad1 -/-(n ϭ 7) bone marrow relative to Mad1 ϩ/ϩ (n ϭ 6) littermates. Immature committed CFCs and mature limited proliferative potential cluster-FCs were assayed in cultures of 25 000 bone marrow cells following stimulation with 1000 U/ml GM-CSF (A) or 1000 U/ml G-CSF (B). Cluster-FC frequencies were calculated by subtracting the number of colonies on day 7 from the number of clusters on day 2. Mature bone marrow granulocyte and macrophage cell numbers were determined by FACS with anti-Mac1 and anti-Gr-1 (Mac1/CD11b is expressed on both granulocytes and macrophages in 129/Sv mice). GM-CSF-and G-CSF-responsive cluster-FCs were significantly more abundant in Mad1 -/-mice (clusterFCs and mature cells, PϽ0.01). (C) Colonies (Ͼ50 cells by day 7 of culture) derived from G-CSF-stimulated Mad1 ϩ/ϩ and Mad1 -/-CFCs were classified on the basis of cell number per colony. Mad1 -/-colonies were significantly larger in size (mean cell number/colony: Mad1 ϩ/ϩ , 117 Ϯ 14; Mad1 -/-, 173 Ϯ 17; n ϭ 27 and 23, respectively; PϽ0.02). Similar results were obtained with GM-CSF. Data represent mean values Ϯ SEM.
( Figure 3C ). A similar expression pattern for Mad1 mRNA has been observed during granulocytic differentiation of human HL-60 cells (Larsson et al., 1994) . We were unable to perform analogous experiments in primary cells since cluster-FCs cannot be purified to homogeneity; however, 
MAD1 is detectable in mature primary granulocytes by immunofluorescence (data not shown).
These results demonstrate that loss of MAD1 leads to an increased frequency of granulocytic cluster-FCs, without any change in the frequency of CFCs, the immediate precursors of cluster-FCs. However, as noted above, despite as much as a 3-fold increase in the frequency of granulocytic cluster-FCs in Mad1 -/-mice, the frequency of terminally differentiated post-mitotic granulocytes in the bone marrow was only slightly elevated ( Figure 2A and B), and was unaffected in the periphery (see Figure  6A below). This observation suggests that a compensatory mechanism must operate to maintain normal levels of mature cells in Mad1 -/-animals despite the increase in cluster-FCs (see below).
Given the ability of ectopically expressed MAD1 to inhibit cell cycle progression Roussel et al., 1996) , a reasonable hypothesis to explain these results would be that the increased cluster-FC frequency is due to a decreased ability of these cells to exit the cell cycle, which is a prerequisite for completion of terminal differentiation. To confirm these findings, we therefore examined the proliferative capacity of differentiating Gand GM-CSF-responsive precursors by labeling bone marrow cells with the intracellular fluorescent dye 5-(and -6)-carboxyfluorescein diacetate succinimidyl ester (CFSE), which allows the cumulative number of divisions which cells have undergone since labeling to be estimated due to the halving of fluorescence intensity that occurs with each division (Lyons and Parish, 1994) . Following stimulation with G-or GM-CSF, Mad1 -/-precursors were found to exhibit increased proliferation as terminal differentiation occurred ( Figure 4A-D) . Analogous results were also obtained by performing these experiments in 778 the presence of 5-bromo-2Ј-deoxyuridine (BrdU) to label newly synthesized DNA ( Figure 4E and F) . Therefore, Mad1 -/-granulocytic precursors undergo increased proliferation prior to becoming post-mitotic. If this observed increase in cluster-FCs in Mad1 -/-mice were cell autonomous, colonies derived from CFCs would be expected to produce more cluster-FCs, and hence be larger in size. Indeed, when bone marrow cells were stimulated with G-CSF at low cell density (to minimize the indirect effects of cell numbers on proliferation), Mad1 -/-CFCs gave rise to colonies that were significantly larger in size than those derived from Mad1 ϩ/ϩ littermates ( Figure 2C ). Consistent with this increase in cluster-FCs occurring in vivo, analysis of primary bone marrow cytospins revealed that the frequency of granulocytic precursors of promyelocyte/myelocyte morphology was increased in Mad1 -/-animals (142 Ϯ 19% relative to Mad1 ϩ/ϩ ). Taken together, these results indicate that granulopoiesis in Mad1 -/-mice is characterized by ectopic cell divisions occurring in a cell-autonomous fashion between the CFC and post-mitotic stages, resulting in delayed terminal differentiation.
Increased sensitivity of MAD1-deficient cells to cytokine withdrawal
As mentioned above, despite an increase in the number of granulocytic cluster-FCs in the bone marrow of Mad1 -/-mice, the numbers of terminally differentiated post-mitotic granulocytes were almost unaffected (Figure 2A and B; also see Figure 6A below). One possible explanation for this disproportionality could be a compensatory decrease in cell survival. Bone marrow hematopoiesis is characterized by the generation of cells in considerable excess, resulting in extensive apoptotic cell death (McKenna and Cotter, 1997) . This is particularly prevalent during the later stages of granulocyte differentiation, with Ͼ90% of bone marrow granulocytes failing to survive and exit into the periphery (Metcalf et al., 1995) . Apoptosis in the bone marrow is believed to be due in part to competition for the sub-maximal levels of cytokines present in vivo, and The percentage of total cells in each culture that have divided at least once is also indicated (ജ1 Div). Mad1 -/-granulocyte precursors exhibited an increased proliferative fraction. CFSE staining of granulocytes resulted in the signal intensity being a continuum rather than the discrete peaks for each cell division previously observed for lymphocytes (Lyons and Parish, 1994) . This is due to heterogeneity in granulocyte cell size resulting in the coefficient of variation (see width of 0 division peak) being much higher than for lymphocytes. (E and F) Representative FACS profiles of bone marrow cells from Mad1 ϩ/ϩ (E) and Mad1 -/-(F) mice (n ϭ 2 for each genotype) metabolically labeled with BrdU and stimulated with 1000 U/ml GM-CSF for 72 h. Cells were stained with propidium iodide in order to detect relative DNA content. The area in the dashed boxes indicates the percentage of total cells that had entered the cell cycle and taken up BrdU. Wildtype (ϩ/ϩ); homozygous mutant (-/-); divisions (Div). and Mad1 -/-(j) mice were cultured in semi-solid media as in Figure  2 , with the exception that 1000 U/ml G-CSF (A) or 1000 U/ml GM-CSF (B) were added only following 24 or 48 h of culture in the absence of cytokines. Cluster-FC survival (as a percentage of the maximum) following cytokine deprivation was significantly decreased in Mad1 -/-animals (PϽ0.05 at 24 and 48 h). Data represent mean values Ϯ SEM (n ജ3 for each genotype). Wild-type (ϩ/ϩ); homozygous mutant (-/-). hematopoietic cells are highly sensitive to undergoing apoptosis when deprived of such survival factors (McKenna and Cotter, 1997) . To examine the sensitivity of Mad1 -/-myeloid cells to apoptosis-inducing limiting cytokine conditions, in vitro clonogenic survival assays were performed in which cytokines were added following an initial period of culture in their absence. Delayed addition of G-or GM-CSF resulted in a significant decrease in cluster formation from Mad1 -/-bone marrow with respect to that of control littermates, indicating that Mad1 -/-granulocyte precursors exhibit decreased ability to survive under limiting cytokine conditions ( Figure  5A and B). Continuous culture at intermediate cytokine concentrations resulted in a dose-dependent decrease in cluster-FC survival (data not shown). Consistent with these results, Mad1 -/-granulocytic cluster-FCs also exhibited a 30-50% increased sensitivity to several other apoptosisinducing stimuli, such as γ-irradiation and doxorubicin treatment (data not shown). Importantly, these effects were again restricted specifically to cluster-FCs, as the sensitivity of immature CFCs to cytokine withdrawal was unchanged in Mad1 -/-animals. Similarly, the in vivo apoptosis of terminally differentiated post-mitotic cells (as measured by TUNEL or annexin V assays) and their in vitro survival under limiting cytokine conditions was also unchanged in Mad1 -/-mice. These results suggest that the observed imbalance between the frequencies of granulocytic cluster-FCs and mature bone marrow and peripheral granulocytes is due to the decreased survival of cluster-FCs in Mad1 -/-mice.
It is important to point out that it is not possible at present to examine apoptosis of cluster-FCs directly in Mad1 -/-mice. This is due to the relative scarcity of granulocytic cluster-FCs as compared with terminally differentiated cells in the bone marrow, as well as the lack of available procedures to purify cluster-FCs to homogeneity. Furthermore, the rapid clearing of apoptotic granulocytes by phagocytosis results in only a small fraction being labeled in standard apoptosis assays (Metcalf et al., 1995; Liu et al., 1996) . However, given that withdrawal of cytokines from primary hematopoietic cells and non-transformed hematopoietic cell lines invariably results in apoptotic cell death (McKenna and Cotter, 1997) , it is likely that the decreased survival of Mad1 -/-granulocytic cluster-FCs in vitro is due to an increased rate of apoptosis.
Enhanced recovery of Mad1 null mice following bone marrow ablation
These observations suggest that homeostatic compensation for delayed granulocyte differentiation in Mad1 -/-mice is due to a cell-autonomous decrease in cell survival, resulting in essentially normal numbers of mature bone marrow and circulating peripheral blood granulocytes. To examine granulopoiesis in Mad1 -/-animals under conditions where the hematopoietic compartment is not at a steady-state equilibrium, proliferating bone marrow precursors were ablated by i.v. injection of 5-fluorouracil (5-FU). Suppression of hematopoiesis following this treatment occurred to a similar extent in Mad1 -/-and Mad1 ϩ/ϩ mice ( Figure 6A ). Strikingly, however, by 14 days following 5-FU treatment the mature peripheral blood and splenic granulocytes had recovered to significantly higher levels in Mad1 -/-than Mad1 ϩ/ϩ mice ( Figure 6A and B) . Similarly, increased numbers of granulocytic cluster-FCs were observed in the bone marrow and spleen of Mad1 -/-animals ( Figure 6C ). As described above, this is in contrast to the normal numbers of mature splenic and peripheral blood granulocytes observed in untreated Mad1 -/-animals. This effect was again stage specific as there was no significant difference in number of more immature bone marrow CFCs. These results are consistent with Mad1 -/-mice having a larger granulocyte cluster-FC pool due to delayed terminal differentiation, and suggest that the compensatory decrease in survival of cluster-FCs observed in Mad1 -/-mice is over-ridden during recovery from granulocytopenia.
Mad gene family redundancy in Mad1 knockout mice
In contrast to the inhibition of cell cycle exit during granulocyte differentiation in Mad1 -/-mice, other hematopoietic cell types were less obviously affected. For example, Mad1 -/-mice exhibited a small increase in the frequency of low proliferative-potential erythroid and Fig. 6 . Recovery of the granulocytic lineage in Mad1 -/-mice following bone marrow ablation. Bone marrow ablation was performed in Mad1 -/-(n ϭ 4) and Mad1 ϩ/ϩ (n ϭ 4) mice by i.v. injection of 5-FU. Peripheral blood counts and smears were performed on intra-orbital blood on days 0, 7 and 14 following 5-FU injection (A). The frequency of Gr-1 ϩ mature granulocytes was determined by FACS on day 14 (B), and the frequency of G-CSF responsive cluster-FCs was determined as in Figure 2C (C). Peripheral granulocytes and cluster-FC reached significantly higher levels in Mad1 -/-animals relative to controls (PϽ0.05). Mature bone marrow granulocytes in wild-type and mutant mice returned to approximately steadystate levels by day 14 (B). On day 7 following 5-FU treatment (A), circulating granulocytes were suppressed to an identical extent in the Mad1 ϩ/ϩ controls and two of four Mad1 -/-animals. Although two other Mad1 -/-animals exhibited slightly higher numbers, this difference did not affect the extent of recovery observed on day 14. Data represent mean values Ϯ SEM. Peripheral blood (PB); bone marrow (BM); red blood cell (RBC); spleen (S). macrophage precursors (™120% of wild-type; PϽ0.05), and the survival of these cells following delayed addition of erythropoietin (Epo) or macrophage colony-stimulating factor (M-CSF) was also reduced (™70% of wild-type; PϽ0.05). Additionally, Mad1 -/-resting B lymphocytes were found to re-enter the cell cycle significantly more rapidly than wild-type cells, as determined by BrdU labeling following in vitro stimulation with mitogenic bacterial lipopolysaccaride (LPS) (fraction labeled after 48 h: Mad1 ϩ/ϩ , 28.0 Ϯ 1.7%; Mad1 -/-, 37.8 Ϯ 1.7%; PϽ0.01). This suggests that MAD1 may play a role in cell cycle arrest of mature B cells, although Mad1 -/-mice produced normal levels of serum immunoglobulins and were not prone to spontaneous infection when housed under non-pathogen-free conditions. However, by histology, other tissues appeared to differentiate normally, and a careful examination of neural differentiation did not reveal any evidence for ectopic mitosis, delayed differentiation or decreased cell survival.
The restriction of the Mad1 -/-phenotype primarily to the granulocytic lineage may be explained by the fact that Mad1 is one of four members of the Mad gene family, each of which is expressed in overlapping but distinct patterns (Hurlin et al., 1995b; Quéva et al., 1998) . Although MAD1 is the most extensively studied family member, other MADs appear to behave similarly in vitro and in tissue culture systems (Hurlin et al., 1995b) . Hence, there is considerable potential for genetic redundancy among the Mad family. Functional compensation might also occur through up-regulation of other MAD family members in the absence of MAD1. To address this possibility, mRNA in situ hybridizations were performed to examine the expression patterns of other members of the Max network in Mad1 -/-mice. Two Mad1-related genes were found to be ectopically expressed in the spleens of Mad1 -/-animals: Mxi1 was induced in the red pulp surrounding lymphoid follicles ( Figure 7C and D); and Mad3 was up-regulated in lymphoid germinal centers ( Figure 7E and F). Both these regions normally express high levels of Mad1 ( Figure 7A ). However, there were no 
Discussion
It is well established that cell cycle withdrawal and terminal differentiation are tightly coupled processes in most cell types. The G 0 /G 1 arrest of cells prior to terminal differentiation typically requires down-regulation of MYC expression (Coppola and Cole, 1986; Freytag, 1988) . With the concomitant up-regulation of MAD1, this leads to MYC-MAX complexes being replaced rapidly by MAD1-MAX complexes Hurlin et al., 1995b; Cultraro et al., 1997) . Given the ability of ectopically expressed MAD1 to promote G 1 arrest and antagonize MYC-dependent transcription and transformation (see Introduction), we have proposed that induction of MAD1 plays an important role in mediating cell cycle withdrawal during terminal differentiation.
To test this hypothesis, we generated targeted disruptions of the Mad1 gene in mice. Although Mad1 -/-mice were viable and outwardly normal in appearance, we found that cell cycle exit of granulocytic precursors was delayed following the CFC stage, as evidenced by an increased number of cell divisions occurring between the CFC and post-mitotic stages of differentiation. This conclusion is based on both the increased frequency of cluster-FCs detected in vivo and the enhanced proliferative capacity of CFCs measured in vitro. In contrast, the number of terminally differentiated granulocytes was found to be largely unaffected in Mad1 -/-mice. We did find, however, that granulocytic cluster-FCs exhibited increased sensitivity to apoptosis-inducing conditions, raising the possibility that decreased cell survival accounts for the observed imbalance between precursor and mature granulocytes during steady-state hematopoiesis in vivo. Further, Mad1 -/-mice exhibited enhanced recovery of peripheral granulocyte populations following bone marrow ablation, probably reflecting the increased proliferative capacity of CFCs in these animals. Taken together, these results provide the first direct demonstration that MAD1 functions to mediate cell cycle withdrawal during terminal differentiation, and also suggest that competition between MYC and MAD1 regulates a balance between granulocyte proliferation and terminal differentiation.
The oncogenic activation of MYC typically is associated with its overexpression (Marcu et al., 1992) . For example, Eμ-Myc transgenic mice that ectopically express MYC during B cell development are highly predisposed to lymphomas . Interestingly, prior to the onset of neoplasia in Eμ-Myc mice, B cell development is characterized by increased proliferation and apoptosis of pre-B cells at the expense of their further differentiation (Langdon et al., 1986; Jacobsen et al., 1994) . The phenotypes of Mad1 -/-and pre-neoplastic Eμ-Myc mice, although affecting different cell lineages, are similar to one another, consistent with the suggestion that MYC and MAD1 have mutually antagonistic roles in cell proliferation and differentiation, and that the MYC signaling pathway is deregulated in Mad1 knockout mice.
Ectopic expression of MAD1 has been shown to inhibit cell transformation, raising the possibility that it functions as a tumor suppressor in vivo (Lahoz et al., 1994) . However, in contrast to the development of lymphomas in Eμ-Myc mice, Mad1 -/-mice do not exhibit an increased rate of spontaneous neoplasia. This observation suggests that MYC activity may not be deregulated sufficiently to promote tumorigenesis in Mad1 -/-mice, or alternatively that granulocytic cluster-FCs are resistant to transformation by MYC. However, it is also possible that tumors may develop in Mad1 -/-mice only following a long latency period, and that different genetic backgrounds or other cooperating mutations may be required to potentiate tumor formation.
Given the broad expression pattern of the Mad1 gene, it is perhaps surprising that Mad1 -/-animals do not exhibit more generalized defects in cell differentiation. This may be explained in part by functional redundancy between MAD1 and other members of the MAD family, as has been seen recently with other multigene families (Lowell and Soriano, 1996; Molkentin and Olson, 1996; Zhuang et al., 1996) . Furthermore, we have observed that Mxi1 and Mad3 are up-regulated in Mad1 -/-mice, suggesting that compensation might also occur through transcriptional cross-regulation of the Mad gene family. This finding is similar to the previously reported up-regulation of c-Myc in neural cells of N-Myc knockout mice (Stanton et al., 1992) , and may indicate the existence of feedback controls for maintaining the appropriate cellular balance between MYCs and MADs. Targeted disruptions of other Mad genes and the generation of double knockout mice will be required to resolve fully the extent of redundancy among the MAD family.
Commitment to terminal differentiation is likely to be regulated by the convergence of multiple independent regulatory pathways. Thus it is possible that MAD1 acts cooperatively with other unrelated cell cycle inhibitors to promote differentiation. For example, targeted disruption of the retinoblastoma protein RB in mice inhibits terminal differentiation of several cell lineages (Clarke et al., 1992; Jacks et al., 1992; Lee et al., 1992 Lee et al., , 1994 Zacksenhaus et al., 1996) . Interestingly, RB also appears to function in maintaining cells in the G 0 phase of the cell cycle following completion of terminal differentiation (Lee et al., 1994; Schneider et al., 1994; Zacksenhaus et al., 1996) . In contrast, mature Gr-1 ϩ granulocytes from Mad1 -/-mice are incapable of reentering the cell cycle when stimulated with G-and/or GM-CSF (data not shown). This difference between Rb -/-and Mad1 -/-cells may be related to the inability of MYC to induce proliferation in some terminally differentiated cells (Endo and Nadal-Ginard, 1986) .
The CIP/KIP family of cyclin-dependent kinase inhibitors (CKIs) have also been implicated in terminal differentiation. In this regard, it is intriguing that the phenotype of Mad1 -/-mice is similar to those observed due to null mutations in the CKIs Drosophila Dacapo, and murine p21 CIP1 , p27 KIP1 and p57 KIP2 (de Nooij et al., 1996; Lane et al., 1996; Missero et al., 1996; Casaccia-Bonnefil et al., 1997; Yan et al., 1997; Zhang et al., 1997) . All of these mutations lead to delayed terminal differentiation of specific tissues due to low proliferative potential precursors undergoing one or more ectopic divisions prior to cell cycle arrest. The similarity of these phenotypes raises the possibility that these pathways cooperate to mediate cell cycle withdrawal during differentiation, or that there are previously unrecognized epistatic relationships between them.
During development, many examples of programed cell death appear to result from competition between cells for limiting survival factors (Raff, 1992) . The decreased survival of Mad1 -/-granulocytic cluster-FCs under cytokine-limiting conditions suggests that MAD1 may function in part to regulate the sensitivity of cells to MYCinduced apoptosis. Since MAD1 deficiency results in both inhibition of terminal differentiation and decreased cell survival, it is tempting to speculate that both these effects result from a delay in the down-regulation of proliferationassociated genes during terminal differentiation. Interestingly, inhibition of terminal differentiation in RB-deficient mice is also associated with ectopic cell death in several tissues (Lee et al., 1994; Macleod et al., 1996; Zacksenhaus et al., 1996) , and induction of p21 CIP1 during differentiation of myoblast and neuroblastoma cell lines has also been found to enhance cell survival (Poluha et al., 1996; Wang and Walsh, 1996) . Therefore, deregulation of cell cycle exit may generally increase the probability of cell death due to an imbalance between signals promoting cell proliferation (MYC and cyclin-dependent kinases) and other signals promoting differentiation (MAD, RB and CKIs). Alternatively, these genes may directly regulate signaling pathways that mediate cell survival and which are entirely independent of cell proliferation pathways. The combinatorial expression patterns of MYCs, MADs and other cell cycle regulators probably play an important role in providing the diversity of cell numbers that is observed among different tissues and under different environmental conditions, by balancing proliferation, differentiation and cell survival. Detailed analysis of the gene expression patterns in MAD1-deficient cells may provide further insights into these questions.
Materials and methods
Construction of targeting vectors
A human Mad1 cDNA was employed to screen a murine AB1 ES cell cDNA library (Chen et al., 1994) . One of two independent clones was sequenced and found to contain the entire open reading frame of Mad1 (DDBJ/EMBL/GenBank accession No. U20614). This cDNA was used to screen a murine 129/Sv genomic library (G.Friedrich and P. Soriano, unpublished) , and the resulting clones were restriction mapped and sequenced for confirmation. A 5.3 kb SalI-XhoI fragment ( Figure 1A) containing the 5Ј end of the Mad1 gene (including the promoter and exons 1 and 2) was employed to create two different targeting vectors: (i) pMad1 tm1 ( Figure 1A ), in which a 318 bp SacIINotI fragment (encompassing the proximal Mad1 promoter, first exon and 29 bp of the first intron) was replaced by a PGKneobpA cassette, oriented in the opposite transcriptional direction to Mad1; and (ii) pMad1 tm2 , which will be described in detail elsewhere (K.P.Foley, unpublished). In both constructs, the negative selectable marker cassette, PGKtkpA, was introduced between the plasmid backbone and Mad1 'short arm'. Mock PCR-positive control versions of each vector were generated by replacing the PGKtkpA cassette with a 1.75 kb EcoRIXhoI fragment from the Mad1 second intron in its normal orientation.
ES cell procedures
ES cells were manipulated essentially as previously described (Soriano et al., 1991) . Passage 10 AK7 ES cells derived from the 129/Sv mouse strain (A.Imamoto and P. Soriano, unpublished) were cultured on mitomycin C-inactivated, leukemia inhibitory factor-expressing SNL 76/ 7 feeder cells, electroporated with SalI-linearized targeting vectors and placed under positive/negative selection with G418 and FIAU. ES cell colonies surviving after 9 days were analyzed by PCR using the following oligonucleotide primers: K15 (antisense 3Ј primer derived from Mad1 second intron; Figure 1A ), 5Ј-CCAACAGCCACGGAAGAGAT-3Ј; K16 (5Ј sense primer derived from PGK promoter in pMad1 tm1 ; Figure 1A ), 5Ј-GAGCCCAGAAAGCGAAGGAG-3Ј; and K21 (5Ј sense primer derived from polylinker sequence in pMad1 tm2 ; not shown), 5Ј-GT-CTGGATCCCCTCGACCTC-3Ј. Mock targeting vectors (described above) were used initially to establish PCR assay conditions capable of detecting 1 fg of mock target in a background 100 ng of genomic DNA after 40 cycles. These conditions previously have been determined to provide sufficient sensitivity to detect one homologous recombinant ES cell clone in a pool of Ͼ10 non-homologous recombinants (P. Soriano, unpublished) . Between 10 and 20% of each ES cell colony was picked individually or in pools, and lysed in 12 μl of PCR lysis buffer [1ϫ PCR buffer (described below), 1.7 mM SDS, 50 μg/ml proteinase K] by heating at 37°C for 1 h and then at 85°C for 10 min. Aliquots (5 μl) of lysate were amplified in 25 μl PCR reactions containing 1ϫ MGB II [16.6 mM (NH 4 ) 2 SO 4 , 67 mM Tris (pH 8.8), 6.5 mM MgCl 2 , 1 mM each dNTP, 10% dimethyl sulfoxide, 1% β-mercaptoethanol (βME), 0.01% gelatin; A.Imamoto and P.Soriano, unpublished), 2.5 pmol of each appropriate primer (K15 and K16 for Mad1 tm1 , and K15 and K21 for Mad1 tm2 ], 2.5 U of Taq DNA polymerase and 2.5 U of Taq Extender (Stratagene). PCR reactions were performed with the following temperature profiles: an initial denaturation at 95°C for 5 min, then 40 repeating cycles of 93°C for 35 s, 50°C (for Mad1 tm1 ) or 55°C (for Mad1 tm2 ) for 40 s, and 65°C for 3 min 50 s.
Clones were analyzed by Southern blotting with probes diagnostic for the 5Ј (probe A) and 3Ј (probe B) ends of the expected homologous recombination events ( Figure 1A) , and for the neo and tk selectable markers (not shown). Fifteen μg of XbaI-digested genomic DNA was electrophoresed on a 0.8% agarose gel, treated with 0.25 M HCl for 15 min and blotted to Hybond-Nϩ membrane (Amersham) by capillary transfer in 0.4 M NaOH for 3 h. Hybridizations were performed at 65°C for 12 h in FBI buffer (1.5ϫ SSPE, 7% SDS, 10% polyethylene glycol 8000, 100 mg/ml sonicated and boiled salmon sperm DNA), and blots were washed three times at 65°C (in 0.1ϫ SSC, 0.1% SDS) before autoradiography.
ES cell clones were injected into C57BL/6 blastocysts and then transplanted into pseudopregnant females following standard procedures. Nine out of nine clones gave rise to chimeric founders that transmitted the targeted alleles through the germ line. Progeny were genotyped by PCR (as above, but using 50 ng of genomic tail DNA and 27 cycles), heterozygous siblings were interbred, and the resulting F 2 generation analyzed by Southern blotting. Most experiments were performed using 8-to 12-week-old Mad1 ϩ/ϩ and Mad1 -/-littermates. mRNA and protein expression analysis Total RNA was prepared from adult mouse tissues with TRIzol Reagent (Gibco BRL) following the manufacturer's instructions. RT-PCR assays were performed essentially as previously detailed (Leonard et al., 1993) by independently amplifying cDNA with control primers specific for the murine ribosomal protein S16 mRNA, and the following Mad1 primers (63°C annealing temperature): sense exons 5/6 junction, 5Ј-CTCTGATA-GAGAAGAACTGGACG-3Ј; and antisense exon 6, 5Ј-TCGTCCGAGT-CACTCACGCTG-3Ј. Radiolabeled amplification products were electrophoresed on denaturing sequencing gels and visualized by autoradiography.
MPRO cells were cultured as described (Tsai and Collins, 1993) . Differentiation was induced with an RXR agonist, ALGN 19204 (Allergan). This compound is a potent inducer of terminal differentiation of the MPRO cell line (S.Collins, personal communication). MAD1 protein expression was analyzed by radioimmunoprecipitation with antihuman MAD1 polyclonal antisera #C19 (Santa Cruz), essentially as detailed .
Expression of the murine c-Myc, N-Myc, Max, Mad1, Mxi1, Mad3 and Mad4 genes was analyzed by mRNA in situ hybridization using 35 Slabeled riboprobes probes, as previously described (Hurlin et al., 1995b) .
Flow cytometry
Immunostaining was performed by pre-incubating single cell suspensions with anti-Fc receptor antibody 24G.2, followed by incubation with lineage-specific antibodies and 1 μg/ml 7-amino actinomycin-D (Molecular Probes), and analyzed on a FACScan (Becton Dickinson). The following biotin-, fluorescein (FITC)-and phycoerythrin (PE)-labeled antibodies and reagents were employed: biotin-anti-B220, biotinanti-CD34, FITC-anti-Gr-1, FITC-anti-IgM and biotin-anti-Ter119 (Pharmigen); biotin-anti-CD4, FITC-anti-CD8, biotin-anti-c-Kit, PEanti-F4/80, PE-anti-Mac1/CD11b, streptavidin-PE and streptavidin-FITC (Caltag). Statistical analyses for all hematopoietic cell studies were performed using a two-sided unpaired Student's t-test.
Hematopoietic cell culture
All cultures were performed in a 37°C/5% CO 2 fully humidified incubator. Clonal myeloid cultures were performed as previously described (Metcalf, 1984) . Briefly, 2.5ϫ10 4 bone marrow or splenic cells were stimulated in 1 ml of semi-solid media containing 0.3% agar and 20% calf serum (CS; Hyclone) in Dulbecco's modified Eagle's medium (DMEM). After 2 and 7 days, the number of clonogenic cells was determined by stereomicroscopy. Differential counts and determination of colony size were performed on fixed cultures after staining for acetylcholinesterase activity followed by luxol fast-blue and hematoxylin. Clonal erythroid cultures were performed as previously detailed (Metcalf, 1984) . The erythroid nature of colonies was confirmed by staining with acid-benzidene. The following recombinant cytokines were employed: Epo and G-CSF (Amgen); GM-CSF, partially purified interleukin (IL)-3, IL-6 and stem cell factor (Immunex); and M-CSF baculovirus supernatant (L.Rohrschneider). To analyze the effects of cytokine starvation, cytokines were omitted from clonal myeloid and erythroid cultures during the first 24-48 h and then added back by evenly distributing the appropriate quantity of cytokines over the surface of the cultures in 0.2 ml of media.
Cell cycle analysis
To analyze granulocyte precursor cell proliferation, 1ϫ10 5 bone marrow cells/ml were stimulated in suspension with 1000 U/ml G-CSF or GM-CSF (in DMEM containing 20% CS), and cultured in the presence of 10 μM BrdU (Sigma) for 72 h prior to harvesting. Alternatively, cells were labeled with 10 μM CFSE (Molecular Probes). In the latter case, to indicate the fluorescence level of undivided cells, 2 μM colchicine (Sigma) was added following labeling with CFSE. Similarly, to analyze cell proliferation of mature B lymphocytes, 1ϫ10 6 splenocytes were stimulated with 20 μg/ml Escherichia coli LPS (Sigma) in 1 ml of suspension culture (in RPMI 1640 media containing 10% fetal bovine serum, 10 mM L-glutamine and 50 μM βME). BrdU was added after 783 16 h, and cells were harvested after 24-72 h. Following BrdU labeling, granulocytes and B lymphocytes were fixed with 86% ethanol in phosphate-buffered saline (PBS), and then stained with anti-BrdU antibody (Becton Dickinson) and FITC-conjugated goat anti-mouse IgG (Capel) according to the manufacturer's protocols. After staining with 10 μg/ml propidium iodide (PI) (in PBS containing 2% CS), cells were analyzed on a FACScan. The S-phase fraction of MPRO cells was determined by PI staining as above, but including 0.25 mg/ml RNase A.
Bone marrow chemo-ablation
Injections of 5-FU (Sigma) at 150 μg/g body weight (in PBS) were performed via the tail vein. Differential counts and peripheral blood smears were performed from intra-orbital blood on days 7 and 14 following injection. Animals were sacrificed on day 14, mature granulocyte numbers determined by FACS, and granulocytic precursors assayed in vitro as described above.
